Abstract A new procedure for high precision isotope ratio determinations of U, Cu and Zn at nanogram levels in cultured human cells: What are the limiting factors?
首页> 外文期刊>Talanta: The International Journal of Pure and Applied Analytical Chemistry >A new procedure for high precision isotope ratio determinations of U, Cu and Zn at nanogram levels in cultured human cells: What are the limiting factors?
【24h】

A new procedure for high precision isotope ratio determinations of U, Cu and Zn at nanogram levels in cultured human cells: What are the limiting factors?

机译:在培养的人体细胞纳米线水平下高精度同位素比测定的高精度同位素比例的新方法:有什么限制因素?

获取原文
获取原文并翻译 | 示例
           

摘要

AbstractThe monitoring of isotopic fractionations inin vitrocultured human cell samples is a very promising and under-exploited tool to help identify the metabolic processes leading to disease-induced isotopic fractionations or decipher metabolic pathways of toxic metals in these samples. One of the limitations is that the analytes are often present at small amounts, ranging from tens to hundreds of ng, thus making challenging low-uncertainty isotope ratio determinations. Here we present a new procedure for U, Cu and Zn purification and isotope ratio determinations in cultured human neuron-like cells exposed to natural U. A thorough study of the influence of the limiting factors impacting the uncertainty of δ238U, δ66Znand δ65Cuis also carried out. These factors include the signal intensity, which determines the within-day measurement reproducibility, the procedural blank correction and the matrix effects, which determine the accuracy of the mass bias correction models. Given the small Cu and U amounts in the cell samples, 15–30 and 20ng respectively, a highly efficient sample introduction system was employed in order to improve the analyte transport to the plasma and, hence, the signal intensity. With this device, the procedural blanks became the main uncertainty source of δ238Uand δ65Cuvalues, accounting over 65% of the overall uncertainty. The matrix effects gave rise to inaccuracies in the mass bias correction models for samples finally dissolved in the minimal volumes required for the analysis, 100–150μL, leading t
机译:<![cdata [ 抽象 体外的同位素分级的监测培养的人细胞样本是一个非常有前途和 - 利用工具来帮助确定导致疾病诱导的同位素分级或这些样品中有毒金属的破译代谢途径的代谢过程。其中一个局限性是分析物通常以少量存在,从数十到数百个NG等于挑战性低不确定性同位素比例。在这里,我们提出了U,Cu和Zn纯化的新方法,并在暴露于天然U的培养的人神经元样细胞中的同位素比例。彻底研究了影响Δ 238U ,Δ 66zn 和Δ 65cu 是也进行了。这些因素包括信号强度,该信号强度决定了日志测量再现性,程序空白校正和矩阵效应,其确定了质量偏置校正模型的准确性。考虑到细胞样品中的小Cu和U量,分别使用高效的样品引入系统,以改善分析物传输到等离子体,因此,信号强度。使用该设备,程序空白成为Δ 238u 和Δ 65cu 的主要不确定度源价值观,占整体不确定性的65%。基质效应产生了在分析所需的最小体积中的样品中的质量偏压校正模型中的肿块校正模型中的不准确性.100-150μl,领先T.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号